We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

81 hedge funds and large institutions have $79.9M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 15

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

9% more funds holding

Funds holding: 74 → 81 (+7)

10% less capital invested

Capital invested by funds: $88.8M → $79.9M (-$8.89M)

100% less call options, than puts

Call options by funds: $1K | Put options by funds: $1.06M

Holders
81
Holders Change
+7
Holders Change %
+9.46%
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
35
Reduced
15
Closed
9
Calls
$1K
Puts
$1.06M
Net Calls
-$1.06M
Net Calls Change
-$973K

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$4.51M
2
Millennium Management
Millennium Management
New York
+$2.81M
3
VAM
Visium Asset Management
New York
+$2.24M
4
TC
TFS Capital
Pennsylvania
+$1.91M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.32M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$8.7M
2
AG
Algert Global
California
-$939K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$614K
4
BA
Boston Advisors
Massachusetts
-$469K
5
Renaissance Technologies
Renaissance Technologies
New York
-$338K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$582K – – –
GIM
27
Guild Investment Management
California
$576K +$689K +80,553 New
IA
28
Icon Advisers
Colorado
$436K +$522K +61,000 New
TCIM
29
TIAA CREF Investment Management
New York
$379K – – –
JIR
30
James Investment Research
Ohio
$379K +$453K +52,940 New
CS
31
Credit Suisse
Switzerland
$375K +$315K +36,799 +234%
Morgan Stanley
32
Morgan Stanley
New York
$369K +$345K +40,292 +356%
ProShare Advisors
33
ProShare Advisors
Maryland
$332K +$229K +26,756 +136%
Wellington Management Group
34
Wellington Management Group
Massachusetts
$311K +$2.99K +349 +0.8%
ARTA
35
A.R.T. Advisors
New York
$289K +$347K +40,527 New
BIM
36
BlackRock Investment Management
Delaware
$270K -$3.73K -436 -1%
AllianceBernstein
37
AllianceBernstein
Tennessee
$249K -$27.4K -3,200 -8%
GC
38
Globeflex Capital
California
$215K -$22.3K -2,600 -8%
Invesco
39
Invesco
Georgia
$211K -$61.6K -7,200 -20%
Charles Schwab
40
Charles Schwab
California
$211K – – –
GCP
41
GSA Capital Partners
United Kingdom
$204K +$244K +28,526 New
PPA
42
Parametric Portfolio Associates
Washington
$194K +$31.5K +3,680 +16%
DekaBank Deutsche Girozentrale
43
DekaBank Deutsche Girozentrale
Germany
$189K +$21.4K +2,500 +10%
MC
44
Menta Capital
California
$177K +$212K +24,807 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$176K – – –
CCMH
46
Cornerstone Capital Management Holdings
New York
$169K -$38.5K -4,500 -16%
TA
47
Teachers Advisors
New York
$151K – – –
MTIP
48
Magee Thomson Investment Partners
California
$148K – – –
DC
49
Deere & Company
Illinois
$131K -$29.7K -3,472 -16%
AQR Capital Management
50
AQR Capital Management
Connecticut
$129K +$155K +18,100 New
1
2
3 4

SCMP Hedge Fund Activity: Q1 2014 in Review

81 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q1 2014, worth a combined $79.9M — down 10% from $88.8M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new SCMP positions and 9 closed out — a net gain of 7 holders — while 35 added to existing stakes and 15 trimmed.

The largest buyer was Putnam Investments, adding an estimated $4.51M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $8.7M sold.

  • 81 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q1 2014, up from 74 in Q4 2013.
  • Funds reported $79.9M of Sucampo Pharmaceuticals, Inc. stock for Q1 2014, down 10% quarter-over-quarter.
  • 16 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q1 2014 and 9 closed out, a net change of +7 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q1 2014 was Putnam Investments, an estimated $4.51M added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q1 2014 was Consonance Capital Management, an estimated $8.7M sold.

Based on aggregated 13F filings for Q1 2014.